Is Seleniso covered by health insurance? How much is the reimbursement?

Selinexor () is an innovative oral selective nuclear export inhibitor (SINE) that mainly inhibits the growth of cancer cells by blocking the function of the nuclear export protein XPO1. It is indicated for the treatment of relapsed or refractory multiple myeloma (MM) and diffuse large Bcell lymphoma (DLBCL), especially in patients who have failed to respond to other treatment modalities. Selinisol can effectively induce apoptosis in cancer cells while having little impact on normal cells, making it an important choice for targeted therapy.

In China, Seleniso has been approved for marketing and included in the national medical insurance directory. After being included in medical insurance, the financial burden on patients using the drug is significantly reduced. Medical insurance coverage includes the treatment of patients with relapsed or refractory multiple myeloma, and the clear indications allow more patients to obtain this innovative therapy. The specific time and conditions for inclusion in medical insurance need to be subject to the National Medical Insurance Bureau and local medical policies.

After being included in medical insurance, the price of Seleniso has dropped from the previous high level. According to reports, the cost of the drug after being included in medical insurance is about 5,000 to 10,000 yuan, and the specific amount varies slightly depending on hospital purchase prices and regional differences. Through medical insurance reimbursement, the patient's actual payment may be further reduced. The reimbursement ratio is usually between 50% and 80%. The final cost needs to be consulted with the local medical insurance department or hospital pharmacy.

Reimbursement coverage of selinesol provides important support to patients and increases access to the drug. Patients need to understand the medical insurance policy, reimbursement process and medication precautions in detail before use, and strictly follow the doctor's instructions to use medication to achieve the best therapeutic effect.

xa0

Reference materials:

Official website of National Medical Insurance Directory:https://www.nhsa.gov.cn

xa0